MatchTope: A tool to predict the cross reactivity of peptides complexed with Major Histocompatibility Complex I
The therapeutic targeting of the immune system, for example in vaccinology and cancer treatment, is a challenging task and the subject of active research. Several in silico tools used for predicting immunogenicity are based on the analysis of peptide sequences binding to the Major Histocompatibility...
Main Authors: | Marcus Fabiano de Almeida Mendes, Marcelo de Souza Bragatte, Priscila Vianna, Martiela Vaz de Freitas, Ina Pöhner, Stefan Richter, Rebecca C. Wade, Francisco Mauro Salzano, Gustavo Fioravanti Vieira |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.930590/full |
Similar Items
-
Viral immunogenic footprints conferring T cell cross-protection to SARS-CoV-2 and its variants
by: Eduardo Cheuiche Antonio, et al.
Published: (2022-07-01) -
Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues
by: Victor Jaravine, et al.
Published: (2017-12-01) -
Interpreting T-Cell Cross-reactivity through Structure: Implications for TCR-Based Cancer Immunotherapy
by: Dinler A. Antunes, et al.
Published: (2017-10-01) -
Editorial: T cell specificity and cross-reactivity – implications in physiology and pathology
by: Daniela Latorre, et al.
Published: (2024-02-01) -
Protective Role of Cross-Reactive CD8 T Cells Against Dengue Virus Infection
by: Annie Elong Ngono, et al.
Published: (2016-11-01)